Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Regenxbio Inc (RGNX)

Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END

SBFM : 3.30 (+10.37%)
NVAX : 12.52 (-0.32%)
RGNX : 12.50 (-0.24%)
BNTX : 112.51 (-2.69%)
ABBV : 193.62 (+0.35%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

SBFM : 3.30 (+10.37%)
NVAX : 12.52 (-0.32%)
RGNX : 12.50 (-0.24%)
BNTX : 112.51 (-2.69%)
ABBV : 193.62 (+0.35%)
Regenxbio: Q2 Earnings Snapshot

Regenxbio: Q2 Earnings Snapshot

RGNX : 12.50 (-0.24%)
Regenxbio: Q1 Earnings Snapshot

Regenxbio: Q1 Earnings Snapshot

RGNX : 12.50 (-0.24%)
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling?

The threat is still emerging, but it could be significant.

SRPT : 127.10 (+1.67%)
RGNX : 12.50 (-0.24%)
Regenxbio: Q4 Earnings Snapshot

Regenxbio: Q4 Earnings Snapshot

RGNX : 12.50 (-0.24%)
Regenxbio: Q3 Earnings Snapshot

Regenxbio: Q3 Earnings Snapshot

RGNX : 12.50 (-0.24%)
REGENXBIO to Participate in the Jefferies CNS/Neuro Summit

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the Jefferies CNS/Neuro Summit on Thursday, October 12, 2023. Jefferies...

RGNX : 12.50 (-0.24%)
REGENXBIO Presents Interim Clinical Data from Phase I/II AFFINITY DUCHENNEâ„¢ Trial of RGX-202 at 28th Annual International Congress of the World Muscle Society

RGX-202, a potential one-time AAV Therapeutic for the treatment of Duchenne that includes an optimized transgene for a novel microdystrophin, continues to be...

RGNX : 12.50 (-0.24%)
REGENXBIO Announces Presentations at the 28th Annual Congress of the World Muscle Society

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the 28th Annual Congress of the World Muscle Society, taking place in...

RGNX : 12.50 (-0.24%)

Barchart Exclusives

How Surging AI Demand Could Drive This Dividend Stock Higher
Eaton, a diversified power management company, is poised to benefit from the surging demand for AI-driven data centers, with its innovative power solutions and strong dividend growth making it an attractive investment opportunity. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar